Intrinsiqq
Cingulate Inc. logo

Cingulate Inc. Insider Trading

CING

Compare
Last 12 months

Insiders bought 657K on the open market and sold nothing.

Net open-market
+657K
5 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
5 / 0
executives and directors
Last open-market buy
Feb 2026
Feb 13, 2026

Get an email when CING's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Feb 13
    Thomas Jeffrey Hargroves
    Director · bought 97,276 at $5.04
    490K
    50665% of stake
  • Feb 6
    Peter J. Werth
    Director · bought 19,455 at $5.04
    98K
    20% of stake
  • Feb 6
    Jennifer L. Callahan
    SVP and CFO · bought 4,864 at $5.04
    25K
    2494% of stake
  • Feb 6
    Shane J. Schaffer
    Chief Executive Officer · bought 6,809 at $5.04
    34K
    192% of stake
  • Feb 6
    Matthew Brams
    EVP and Chief Medical Officer · bought 1,946 at $5.04
    10K
    72% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CING, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with CING

CompareIntrinsic value
PCSAProcessa Pharmaceuticals Inc.
$1.56-7.69%10
CPIXCumberland Pharmaceuticals Inc.
$5.84-7.30%20
GRIGri Bio Inc.
$1.12+0.00%20
PSTVPlus Therapeutics Inc
No recent price20
EVFMEvofem Biosciences Inc.
$1.00+0.00%15
MBRXMoleculin Biotech Inc.
$7.74-2.40%20
BFRIBiofrontera Inc.
$0.53-7.02%30
LIFDLftd Partners Inc.
$0.11+0.00%35

Spot a number that looks wrong? Check it in CING's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing CING

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.